Definitive Contract HHSN268200900014C

Award Date 2/2/09
Potential Completion Date 7/31/16
Potential Value $3.3M
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
San Francisco, CA 94118, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
23
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,379,807.12 federal contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH), to The Regents of the University of California, San Francisco (UCSF). The contract is for biomedical (applied/exploratory) research and does not have a set-aside designation. UCSF is a leading academic medical center and research institution that receives substantial federal funding for biomedical research, healthcare services,...
The Department of Health and Human Services National Institutes of Health awarded a definitive, cost-no-fee contract to The Regents of the University of California, San Francisco (UCSF) for $6,657,300.68. The contract is for biomedical (basic) services and does not have a set-aside designation. UCSF, a public academic medical center and research university, is providing services through its Controller's Office division. The contract commenced on September 30, 2004 and is scheduled for completion...
This federal contract award is for biomedical research and services, with a total ceiling value of $10,607,389.80. The contract was awarded on March 28, 1996 to the prime contractor, The Regents of the University of California, San Francisco (UCSF), and has an ultimate completion date of February 14, 2013. The contract was awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), a civilian federal agency. The contract is a definitive...
This is a definitive cost-no-fee contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to The Regents of the University of California, San Francisco (UCSF) on June 15, 2010. The contract, valued at $2,025,201.08, supports research on hip morphology and limb-specific risk factors for radiographic hip osteoarthritis. UCSF, a leading academic medical center and research institution, is the prime contractor for this effort....
This $639,119.55 federal contract was awarded by the Department of Health and Human Services' National Institutes of Health National Heart Lung and Blood Institute to The Regents of the University of California, San Francisco (UCSF), a state-controlled institution of higher learning, for the DBDR REDS-III Domestic Site Phase 3 project. The contract is a delivery order under the Recipient Epidemiology and Donor Evaluation Study-III (REDS-III) - Domestic Sites major program, with a period of...
This $765,608.72 federal contract was awarded by the Department of Health and Human Services' National Institutes of Health National Heart Lung and Blood Institute to The Regents of the University of California, San Francisco (UCSF) on September 28, 2017. The contract, which has no set-aside designation, is a Delivery Order under the Recipient Epidemiology and Donor Evaluation Study-III (REDS-III) - International (South Africa) major program to provide services at an international site. UCSF...
This federal contract was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to The Regents of the University of California, San Francisco (UCSF). The contract, valued at $2,630,077.20, is for a STUDY/CHEMICAL-BIOLOGICAL project with a performance period ending on June 30, 2007. UCSF is a leading academic medical center and research institution that frequently partners with federal agencies like the NIDDK to conduct biomedical research,...
This is a $508,058 definitive cost-no-fee contract awarded by the Centers for Disease Control and Prevention (CDC) to The Regents of the University of California, San Francisco (UCSF), a public academic medical center and research university. The contract is for UCSF to perform work under FY22 BAA TOPIC 8, with a period of performance through September 29, 2023. The contract was not set aside for any program. UCSF, through its Controller's Office division, is a leading recipient of federal...
This is a definitive contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to The Regents of the University of California, San Francisco (UCSF) on March 29, 2010. The contract, valued at $1,930,904.73, is for a recovery act project to provide radiologic outcomes for the Osteoarthritis Initiative (OAI), which is sponsored by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). The contract is a firm fixed price arrangement and...
This is a $407,896 federal contract award to The Regents of the University of California, San Francisco (UCSF) by the Centers for Disease Control and Prevention (CDC). The contract is a definitive, cost-no-fee contract with a performance period ending on September 6, 2022. UCSF is a prominent academic medical center and research institution in San Francisco that provides specialized biomedical research, healthcare services, and educational programs to federal agencies through competitive...

This federal contract award was issued by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to The Regents of the University of California, San Francisco (UCSF) on February 2, 2009. The $3,319,012.92 Definitive Contract is for biomedical research and has a period of performance through July 31, 2016. The contract does not have a set-aside designation. As a leading academic medical center and research institution, UCSF has a strong track record of partnering with federal agencies like the NIH to conduct cutting-edge biomedical research through prime contracts and subcontracts. UCSF's extensive federal grant portfolio supports groundbreaking work across various disciplines, including cancer, neuroscience, and infectious diseases, and demonstrates its collaborative efforts with other academic and healthcare organizations.

Generated 11/24/24, 9:39 AM